Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan + amlodipine fixed-dose combination versus amlodipine monotherapy in adults with type 2 diabetes and hypertension
2008-000874-19Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Telmisartan + amlodipine fixed-dose combination with Amlodipine monotherapy (2 arms). Primary endpoint: Change from baseline in mean seated trough cuff systolic blood pressure after 8 weeks. Started Oct 2008; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2008-000874-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000874-19.